Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET

Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET

Abstract Background We aimed to investigate the tau biomarker discrepancies of Alzheimer’s disease (AD) using plasma tau phosphorylated at threonine 181 (p-tau181), cerebrospinal fluid (CSF) p-tau181, and AV1451 positron emission tomography (PET). Methods In the Alzheimer’s Disease Neuroimaging Init...

Full description

Bibliographic Details
Main Authors: Yu Guo, Yu-Yuan Huang, Xue-Ning Shen, Shi-Dong Chen, Hao Hu, Zuo-Teng Wang, Lan Tan, Jin-Tai Yu, the Alzheimer’s Disease Neuroimaging Initiative
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Alzheimer’s Research & Therapy
Subjects:
Alzheimer’s disease
Plasma p-tau181
CSF p-tau181
AV1451 PET
Amyloid-β
Online Access:https://doi.org/10.1186/s13195-021-00834-3

Internet

https://doi.org/10.1186/s13195-021-00834-3

Similar Items